title: Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease.
abstract: Adjuvants can be defined as pharmacological and immunological components that are able to modify and/or enhance antigen-specific immune responses. Based on the interdisciplinary research between immunology and material science/engineering, various vaccine adjuvant materials have been developed. By rational design and engineering of antigen or adjuvant materials, immune-modulatory vaccine systems generated to activate immune system. Here, we review the current progress of bioengineered prophylactic and/or therapeutic vaccine adjuvant for cancer and/or infectious disease, and discuss the prospect of future vaccine adjuvant materials.
authors: SKKU Advanced Institute of Nanotechnology, School of Chemical Engineering, Sungkyunkwan University, Suwon, Korea.
authors: Yong Taik
authors: 0000-0001-5558-5526
authors: YT
authors: Lim
keywords: Immunological adjuvants; Immunomodulation; Immunotherapy
references: J Leukoc Biol. 2005 Mar;77(3):378-87
references: 15582984
references: Immunol Cell Biol. 2004 Oct;82(5):488-96
references: 15479434
references: Immunity. 2006 Sep;25(3):373-81
references: 16979569
references: Annu Rev Immunol. 2002;20:197-216
references: 11861602
references: Trends Immunol. 2009 Jan;30(1):23-32
references: 19059004
references: Immunity. 2006 Sep;25(3):349-60
references: 16979567
references: Curr Top Med Chem. 2013;13(20):2562-80
references: 24066891
references: Curr Opin Immunol. 2010 Jun;22(3):411-6
references: 20466528
references: Proc Natl Acad Sci U S A. 2009 May 12;106(19):7962-7
references: 19416838
references: Nat Rev Immunol. 2006 Feb;6(2):148-58
references: 16491139
references: Nat Med. 2005 Apr;11(4 Suppl):S45-53
references: 15812489
references: Sci Transl Med. 2011 Jul 27;3(93):93ra69
references: 21795589
references: Nat Immunol. 2006 Dec;7(12):1237-42
references: 17110939
references: Cell. 2006 Feb 24;124(4):783-801
references: 16497588
references: Sci Transl Med. 2011 Jun 1;3(85):85ra48
references: 21632986
references: Nat Med. 2007 May;13(5):552-9
references: 17479101
references: Curr Opin Immunol. 2014 Jun;28:58-63
references: 24608070
references: J Immunol. 2006 Apr 15;176(8):4894-901
references: 16585585
references: Nat Mater. 2013 Nov;12(11):978-90
references: 24150416
references: Nature. 2009 Nov 26;462(7272):449-60
references: 19940915
references: Adv Mater. 2012 Jul 24;24(28):3724-46
references: 22641380
references: PLoS One. 2013 May 01;8(5):e61825
references: 23650505
references: Expert Rev Vaccines. 2012 Aug;11(8):995-1007
references: 23002980
references: Nat Rev Immunol. 2004 Apr;4(4):249-58
references: 15057783
references: Nat Immunol. 2004 Oct;5(10):987-95
references: 15454922
references: Nat Med. 2013 Dec;19(12):1597-608
references: 24309663
references: Immunity. 2007 Nov;27(5):687-90
references: 18031690
references: South Med J. 2005 Sep;98 (9):914-20
references: 16217984
references: Int J Pharm. 2013 Jan 2;440(1):27-38
references: 22561794